The observation of decreased acetylation in key glycolytic enzymes following SIRT3 inhibition, notably PGK1 and PGAM, highlights the critical role of acetylation in metabolic enzyme activity regulation, pointing to intricate regulatory networks modulating tumor cell metabolism [42,43]. This evidence concerns the gene SIRT3 and neoplasm.